Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice
Anticancer Research · 2024
DOI: 10.21873/anticanres.17376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Akiko Tateishi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Oncology Department, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Sunitinib. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thoracic Oncology Department, National Cancer Center Hospital, Tokyo, Japan.
- Thoracic Oncology Department, National Cancer Center Hospital, Tokyo, Japan; yokuma@ncc.go.jp.
- Medical Oncology Department, National Cancer Center Hospital, Tokyo, Japan.
- Developmental Therapeutics Department, National Cancer Center Hospital, Tokyo, Japan.
Zitieren
APA
Tateishi, A., Okuma, Y., Goto, Y., Arakaki, M., Igawa, Y. S., Torasawa, M., Shinno, Y., Yoshida, T., Horinouchi, H., Yamamoto, N., & Ohe, Y. (2024). Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice. Anticancer Research. https://doi.org/10.21873/anticanres.17376
Vancouver
Tateishi A, Okuma Y, Goto Y, Arakaki M, Igawa YS, Torasawa M, et al. Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice. Anticancer Research. 2024. doi:10.21873/anticanres.17376
BibTeX
@article{Tateishi2024,
author = {Tateishi, Akiko and Okuma, Yusuke and Goto, Yasushi and Arakaki, Motoko and Igawa, Yukiko Shimoda and Torasawa, Masahiro and Shinno, Yuki and Yoshida, Tatsuya and Horinouchi, Hidehito and Yamamoto, Noboru and Ohe, Yuichiro},
title = {Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17376}
}
EUVIMED